LEPANTO, MARIA STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 1.190
EU - Europa 714
AS - Asia 137
AF - Africa 11
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.060
Nazione #
US - Stati Uniti d'America 1.182
IT - Italia 271
RO - Romania 192
FR - Francia 96
IN - India 66
SE - Svezia 48
CN - Cina 45
DE - Germania 36
FI - Finlandia 13
SG - Singapore 13
BG - Bulgaria 12
AT - Austria 10
MY - Malesia 9
CA - Canada 8
GB - Regno Unito 8
IE - Irlanda 8
TG - Togo 7
RU - Federazione Russa 5
AR - Argentina 3
CL - Cile 3
EG - Egitto 3
PT - Portogallo 3
UA - Ucraina 3
BE - Belgio 2
ES - Italia 2
IR - Iran 2
AU - Australia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EU - Europa 1
GR - Grecia 1
KZ - Kazakistan 1
NL - Olanda 1
SA - Arabia Saudita 1
SI - Slovenia 1
TN - Tunisia 1
Totale 2.060
Città #
Fairfield 193
Horia 189
Rome 131
Ashburn 126
Woodbridge 89
Houston 80
Chandler 79
Seattle 71
Wilmington 71
Cambridge 62
Dearborn 49
Princeton 37
Beijing 29
New York 23
San Paolo di Civitate 21
Lawrence 19
Plano 18
San Diego 18
Millbury 17
San Mateo 16
Ann Arbor 13
Sofia 12
Helsinki 9
Phoenix 9
Boston 8
Dublin 8
Redwood City 8
Lomé 7
Vienna 7
Bremen 6
Norwalk 6
Singapore 6
Tübingen 6
Fremont 5
Andover 4
Bari 4
Hyderabad 4
Bühl 3
El Paso 3
Falls Church 3
Gorizia 3
Lisbon 3
Mentana 3
Milan 3
Nanjing 3
Santiago 3
Toronto 3
Washington 3
Acqui Terme 2
Barcelona 2
Berlin 2
Buenos Aires 2
Elora 2
Fumane 2
Guangzhou 2
Kunming 2
Monte San Giusto 2
San Jose 2
Stratford 2
Thuringen 2
Treviso 2
Zhengzhou 2
Al Mansurah 1
Anagni 1
Assèmini 1
Ben Arous 1
Bern 1
Bonndorf 1
Brisbane 1
Cairo 1
Carassai 1
Ceska 1
Changchun 1
Federal 1
Francavilla al Mare 1
Frankfurt am Main 1
Frosinone 1
Hounslow 1
Ivrea 1
Jeddah 1
Jinan 1
Kolkata 1
Lissone 1
Marino 1
Moscow 1
Naaldwijk 1
Nanchang 1
Napoli 1
Ottawa 1
Perugia 1
Pozzuoli 1
Provo 1
Pune 1
Shenyang 1
Southend 1
Stuttgart 1
Sutton 1
Thessaloniki 1
Togliatti 1
Venezia 1
Totale 1.559
Nome #
Adherent-invasive Escherichia coli (AIEC) in pediatric Crohn's disease patients: phenotypic and genetic pathogenic features 175
Microevolution in fimH gene of mucosa-associated Escherichia coli strains isolated from pediatric patients with inflammatory bowel disease 160
Efficacy of bovine lactoferrin in the post-surgical treatment of patients suffering from bisphosphonate-related osteonecrosis of the jaws: an open-label study 154
Lactoferrin. A natural glycoprotein involved in iron and inflammatory homeostasis 96
Efficacy of lactoferrin oral administration in the treatment of anemia and anemia of inflammation in pregnant and non-pregnant women: an interventional study 90
Aerosolized bovine lactoferrin counteracts Infection, inflammation and iron dysbalance in a cystic fibrosis mouse model of pseudomonas aeruginosa chronic lung infection 90
Bovine lactoferrin pre-treatment induces intracellular killing of AIEC LF82 and reduces bacteria-induced DNA damage in differentiated human enterocytes 90
Lactoferrin efficiently counteracts the inflammation-induced changes of the iron homeostasis system in macrophages 89
Role of lactoferrin and its receptors on biliary epithelium 88
Native and iron-saturated bovine lactoferrin differently hinder migration in a model of human glioblastoma by reverting epithelial-to-mesenchymal transition-like process and inhibiting interleukin-6/STAT3 axis 86
Biotimer assay: A reliable and rapid method for the evaluation of central venous catheter microbial colonization 79
The ferroportin-ceruloplasmin system and the mammalian iron homeostasis machine: regulatory pathways and the role of lactoferrin 79
Physico-chemical properties influence the functions and efficacy of commercial bovine lactoferrins 79
Influence of oral administration mode on the efficacy of commercial bovine Lactoferrin against iron and inflammatory homeostasis disorders 79
Role of lactobacilli and lactoferrin in the mucosal cervicovaginal defense 74
Characterization of the ear canal bacterial flora present in hearing Aids (HA) wearing subjects 74
Lactoferrin in aseptic and septic inflammation 73
Lactoferrin differently modulates the inflammatory response in epithelial models mimicking human inflammatory and infectious diseases 71
Quo vadis lactoferrin? 71
BioTimer assay as complementary method to vortex-sonication-vortex technique for the microbiological diagnosis of implant associated infections 66
Features of uropathogenic escherichia coli able to invade a prostate cell line 63
Lactoferrin's anti-cancer properties:safety, selectivity, and wide range of action 57
Viral hepatitis and iron dysregulation: molecular pathways and the role of lactoferrin 51
Lactoferrin and oral pathologies: a therapeutic treatment 43
The treatment of black stain associated with of iron metabolism disorders with lactoferrin: a litterature search and two case studies 42
Different iron-handling in inflamed small and large cholangiocytes and in small and large-duct type intrahepatic cholangiocarcinoma 37
Coriander (Coriandrum sativum L.) essential oil: effect on uropathogenic Escherichia coli 34
Totale 2.190
Categoria #
all - tutte 4.916
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.916


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019130 0 0 0 0 0 0 0 0 0 0 86 44
2019/2020549 38 9 11 19 60 90 80 60 61 55 49 17
2020/2021542 28 31 100 201 23 15 7 8 71 31 13 14
2021/2022325 10 17 32 16 33 3 9 32 21 18 81 53
2022/2023302 56 72 27 35 24 25 13 10 29 2 7 2
2023/2024173 7 25 19 11 21 50 3 10 5 18 4 0
Totale 2.190